Annual Meeting of the Japanese Heart Rhythm Society 2019

Program

Symposium

1. Silent Atrial Fibrillation: Epidemiology, Diagnosis, and Treatment

July 25 (Thu) 08:30-10:00 Room 1 (Main Hall, 1F, Conference Center)

Chairs Shinichi Niwano, Department of Cardiovasucular Medicine, Kitasato University School of Medicine, Japan

Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia

SY1-1-KL.

Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia

SY1-2. Comparison of 24-Hour vs. 2-Week Continuous Monitoring for Detecting Unknown Atrial Fibrillation Among Patients Without Prior Episodes of Atrial Fibrillation in Japan (REAL-AF study)

Koichi Nagashima, Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Japan

SY1-3. Monitoring and Detecting Silent Atrial Fibrillation Using Wearable Devices in an Era of Digital Evolution

Keitaro Senoo, Department of Cardiac Arrhythmia Research and Innovation, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Japan

SY1-4. Left Ventricular Stiffness Assessed by Diastolic Wall Strain Predicts Infrequent and Asymptomatic Atrial Fibrillation

Takanao Mine, Hyogo College of Medicine, Japan

SY1-5. Catheter Ablation of Silent Paroxysmal Atrial Fibrillation with Intense Follow-Up Using an Extended External Auto-Triggered Loop Recorder

Shinsuke Miyazaki, University of Fukui, Japan


2. Impact of Beta Blockades in the Treatment of Arrhythmias: From Bench to Bedside

July 25 (Thu) 14:30-16:00 Room 1 (Main Hall, 1F, Conference Center)

Chairs Katsushige Ono, Department of Pathophysiology, Oita University School of Medicine, Japan

Peng-Sheng Chen, Indiana University School of Medicine, USA

SY2-1-KL. The Importance of Beta 2 Blockade in Cardiac Arrhythmia Control

Peng-Sheng Chen, Indiana University School of Medicine, USA

SY2-2. Heart Rate Control Resistant Minor Allele of GJA-1 Gene Polymorphism in Patients with Persistent Atrial Fibrillation

Sho Okamura, Hiroshima University, Japan

SY2-3. Role of a Beta Blockade in the Management of Patients Undergoing Pulmonary Vein Isolation of Paroxysmal Atrial Fibrillation

Shinsuke Miyazaki, University of Fukui, Japan

SY2-4. Comparison between Bisoprolol Transdermal Patch and Bisoprolol Fumarate Oral Formulation in Rate Control Therapy of Circadian Variation in Patients with Permanent Atrial Fibrillation

Yohei Sawa, Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Japan


3. Current Status and Future Perspective of AI-based Diagnosis of Arrhythmias

July 25 (Thu) 17:00-18:30 Room 1 (Main Hall, 1F, Conference Center)

Chairs Tetsuo Sasano, Department of Cardiovascular Physiology, Tokyo Medical and Dental University, Japan

Prashanthan Sanders, University of Adelaide, Australia

SY3-1-KL. Current Status and Perspective of the Application of Artificial Intelligence in the Diagnosis of Arrhythmia

Prashanthan Sanders, University of Adelaide, Australia

SY3-2. Deep Neural Network for Estimation of Membrane Potential Distribution from Multiple Electrode Measurement Signals—A Simulation Study

Naoki Tomii, The University of Tokyo, Japan

SY3-3. Deep Convolutional Neural Networks for the Discrimination of Patients with Paroxysmal Atrial Fibrillation on ECG at Sinus Rhythm

Ryouta Mieda, Tokyo Medical and Dental University Department of Cardiovascular Surgery, Japan

SY3-4. What Can Advances in AI Give for AF Detected by Wearables?

Keitaro Senoo, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of Cardiac Arrhythmia Research and Innovation, Japan

SY3-5. Future Perspective of Online Real-Time Atrial Fibrillation Visualization System Aided by Artificial Intelligence and In Silico Analysis System

Takashi Ashihara, Department of Cardiovascular Medicine, Shiga University of Medical Science, Japan


4. Automaticity of the Heart: New Insight

July 25 (Thu) 17:00-18:30 Room 2 (501+502, 5F, Conference Center)

Chairs Haruo Honjo, Research Institute of Enviromental Medicine, Nagoya University, Japan

Yael Yaniv, Biomedical Engineering,Technion – Israel Institute of Technology, Israel

SY4-1. Brain and Pacemaker Signatures in the ECG

Yael Yaniv, Biomedical Engineering,Technion–Israel Institute of Technology, Israel

SY4-2. Learn from Failure: Clock Coupling Rescues Sinoatrial Nodal Cells’ Action Potential Failure

Kenta Tsutsui, Department of Cardiovascular Medicine, Saitama International Medical Center, Faculty of Medicine, Saitama Medical University, Japan

SY4-3. Automaticity in Cardiomyocytes Derived from iPS Cells

Jong-Kook Lee, Department of Advanced Cardiovascular Regenerative Medicine Osaka University Graduate School of Medicine, Japan

SY4-4. The Reentry Circuit of Sinoatrial Reentrant Tachycardia Involves the Sinoatrial Conduction Pathways in Humans: Observation by Noncontact Mapping System

Motoki Hara, Higashihiroshima Medical Center, Japan


5. Latest Technology for Scar-related Reentrant VTs—Searching for the Optimal Endpoint

July 25 (Thu) 08:30-10:00 Room 5 (302, 3F, Conference Center)

Chairs Akihiko Nogami, Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan

Saurabh Kumar, Ventricular Arrhythmias and Sudden Cardiac Death at Westmead Hospital, Australia

SY5-1-KL.

Saurabh Kumar, Ventricular Arrhythmias and Sudden Cardiac Death at Westmead Hospital, Australia

SY5-2. Long-Term Outcome of Ventricular Tachycardia Ablation in Patients Who Did Not Undergo Ventricular Tachycardia Induction after Ablation

Takeshi Kitamura, Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Japan

SY5-3. Late Potential Abolition Strategy for VT in Patients with Non-Ischemic Cardiomyopathy

Kenji Okubo, Yokosuka Kyosai Hospital, Japan

SY5-4. Targeting the Evoked Delayed Potential Reduces VT Recurrence after Catheter Ablation in Patients with Subendocardial Myocardial Infarction

Yoshihisa Naruse, Hamamatsu University School of Medicine, Japan

SY5-5. Feasibility of Real-Time Magnetic Resonance Imaging-Guided Radiofrequency Catheter Ablation of Ventricular Tachycardia

Susumu Tao, Department of cardiovascular medicine / Heart rhythm center, Tokyo Medical and Dental University, Japan

SY5-6. Ablation of CT-Derived Wall Thickness Channels in Post-Infarction Ventricular Tachycardia: Comparison to Conventional LAVA Elimination Strategy

Masateru Takigawa, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France


6. Current Topics of Inherited Arrhythmias

July 26 (Fri) 08:30-10:00 Room 1 (Main Hall, 1F, Conference Center)

Chairs Wataru Shimizu, Department of Cardiovascular Medicine, Nippon Medical School, Japan

Naomasa Makita, National Cerebral and Cardiovascular Center Research Institute, Japan

SY6-1. A Novel Mechanism of Sinus Node Dysfunction: Intergenic Deletion between PITX2 and ANK2 Disrupts Chromatin Structure in Pacemaker Cell Differentiation

Hiroshige Murata, Nippon Medical School, Japan

SY6-2. Functional Reappraisal of SCN5A Mutations Reemphasize Their Predictive Value for Lethal Cardiac Events in Brugada Syndrome

Taisuke Ishikawa, Omics Research Center, National Cerebral and Cardiovascular Center, Japan

SY6-3. MicroRNAs and Brugada Syndrome

Yukiko Nakano, Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan

SY6-4. Significance of Exercise-Induced Ventricular Arrhythmias in patients with Brugada Syndrome

Hiroshi Morita, Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Japan

SY6-5. Quantitative Microvolt T-Wave Alternans Monitoring for Risk Assessment and Guiding Therapy in Patients with Long QT Syndrome

Nobuhiro Takasugi, Division of Cardiovascular Medicine, Gifu University Hospital, Japan


7. How to Ablate Idiopathic Ventricular Arrhythmias Difficult to Map and Access the Origins of Arrhythmias

July 26 (Fri) 10:00-11:30 Room 1 (Main Hall, 1F, Conference Center)

Chairs Hiroshi Tada, Department of Cardiovascular Medicine, Faculty of Medical Sciences,University of Fukui, Japan

Takumi Yamada, Division of Cardiovascular Disease, University of Alabama at Birmingham, USA

SY7-1-KL. Why Does Catheter Ablation Remain Challenging in Some Idiopathic Ventricular Arrhythmias?

Takumi Yamada, Division of Cardiovascular Disease, University of Alabama at Birmingham, USA

SY7-2. Outcome of Combined Radiofrequency- and Cryo-ablation in Patients with Ventricular Arrhythmias Originating from the Papillary Muscles/Moderator Band

Koji Miyamoto, Mayo Clinic, USA/ Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan

SY7-3. Challenging Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias from Distal of Great Cardiac Vein or their Branches

Yasuaki Tanaka, Yokosuka Kyosai Hospital, Japan

SY7-4. Catheter Ablation of Left Ventricular Arrhythmias Using the Real-Time Three-Dimensional Anatomic Geometry from Ultrasound

Atsuyuki Watanabe, Cardiovascular of medicine,Okayama University, Japan

SY7-5. Long Duration Ablation on Left Ventricular Endocardium using Remote Magnetic Navigation System for Premature Ventricular Contraction from the Summit of Left Ventricle

Soichiro Yamashita, Heart Rhythm Center, Aijinkai Takatsuki Hospital, Osaka, Japan

SY7-6. Intramural Infusion Needle Ablation for Intractable Premature Ventricular Contractions Associated with Ventricular Dysfunction

Tomofumi Nakamura, Vanderbilt University Medical Center, USA


8. An Alarming Growth of AF Population-How to Use Oral Anticoagulants Safely

July 26 (Fri) 14:00-15:30 Room 1 (Main Hall, 1F, Conference Center)

Chairs Takeshi Yamashita, The Cardiovascular Institute, Japan

Yukihiro Koretsune, National Hospital Organization Osaka National Hospital, Japan

SY8-1-KL. State-of-the-Art

Takeshi Yamashita, The Cardiovascular Institute, Japan

SY8-2. Importance of Stroke Prevention by Appropriate Oral Anticoagulant Use in Elderly Japanese Patients—Findings from the SAKURA AF Registry

Yasuo Okumura, Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Japan

SY8-3. Clinical Characteristics and Outcomes in Elderly Japanese Patients with Nonvalvular Atrial Fibrillation: The Hokuriku-Plus AF Registry

Toyonobu Tsuda, Kanazawa University Hospital

SY8-4. Risk of Triple Antiplatelet Therapy in Atrial Fibrillation Patients Undergoing Coronary Stenting

Yukio Sekiguchi, Department of Cardiology, University of Tsukuba, Japan

SY8-5. Strategies for Ischemic and Hemorrhagic Strokes during Anticoagulation Treatments in the Era of Specific Reversal Agents

Shigeru Nogawa, Department of Neurology, Tokai University Hachioji Hospital, Japan


9. Recent Advantages in Balloon-based Atrial Fibrillation Ablation

July 26 (Fri) 16:30-18:00 Room 1 (Main Hall, 1F, Conference Center)

Chairs Kazuhiro Satomi, Heart Rhythm Center, Tokyo Medical University Hospital

Carlo De Asmundis, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Belgium

SY9-1-KL.

Carlo De Asmundis, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Belgium

SY9-2. Comparison of Acute Effect and Clinical Outcome among Various Balloon Systems in Paroxysmal Atrial Fibrillation Patients

Seigo Yamashita, The Jikei University School of Medicine, Japan

SY9-3. The Impact of Additional Freeze Cycles on Ablation Lesions and Gaps for Cryoballoon Ablation of Paroxysmal Atrial Fibrillation in the AD-Balloon Study

Koji Miyamoto, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan/Mayo Clinic, USA

SY9-4. Time to Isolation Guided Hot Balloon Ablation for Pulmonary Vein Isolation

Akio Chikata, Division of Cardiology, Department of Internal Medicine, Toyama Prefectural Central Hospital, Japan

SY9-5. Procedural Outcomes of Pulmonary Vein Isolation Using Visually Guided Laser Balloon in Japanese Patients: A Multicenter Study

Yoshihide Takahashi, Advanced Arrhythmia Research, Tokyo Medical and Dental University, Japan

SY9-6. Influence of Various Energy Settings and Overlap Ratios on Size and Continuity of Lesions in Laser Balloon Ablation in Ex Vivo Mode

Takahiko Nagase, Saitama Medical University International Medical Center, Japan

SY9-7. The Incidence of Esophageal Thermal Lesions and Gastroparesis after Luminal Esophageal Temperature-Guided Pulmonary Vein Isolation Using Radiofrequency and Cryoballoon Catheter

Yasuhiro Yoshiga, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Japan


10. Novel Strategy of Catheter Ablation for Persistent Atrial FibrillationーHow to Optimize Extra-PV Substrate Modification

July 26 (Fri) 10:00-11:30 Room 4 (301, 3F, Conference Center)

Chairs Kaoru Okishige, Yokohama City Minato Red Cross Hospital, Japan

Young-Hoon Kim, Korea University Medical College, Anam Hospital, Korea

SY10-1-KL.

Young-Hoon Kim, Korea University Medical College, Anam Hospital, Korea

SY10-2. Combined Real-Time Dominant Frequency and Phase Mapping (ExTRa Mapping) May Contribute to Identifying Important Arrhythmogenic Atrial Regions in Persistent AF

Koji Kumagai, Department of Cardiovascular Medicine, Tohoku Medical and Pharmaceutical University, Japan/Mayo Clinic, USA

SY10-3. Two-Year Follow-Up of a New Tailored Approach for Persistent Atrial Fibrillation: Early Area Defragmentation (EADF)

Masatsugu Ohe, Kurume university, Japan

SY10-4. The Effects of the Catheter Maze Procedure, "Box-Isolation+Three Mitral-Lines," on Persistent Atrial Fibrillation

Motoki Hara, Higashihiroshima Medical Center, Japan

SY10-5. Does Epicardial Marshall Vein Alcoholization Add Benefit on Conventional Endocardial RF Ablation in Perimitral Flutter?

Masateru Takigawa, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France

SY10-6. Safety and Feasibility of Novel Extensive Ablation Strategy Inducing Cryoballoon Ablation for Non-Paroxysmal Atrial Fibrillation in High-Risk Patients

Takeshi Sasaki, National Disaster Medical Center, Japan

SY10-7. Impact of Posterior Wall Isolation in Conjunction with Pulmonary Vein Isolation Using Cryoballoon Ablation in Patients with Persistent Atrial Fibrillation: A Single Center Experience

Masahiro Esato, Department of arrhythmia, Ijinkai Takeda General Hospital, Japan


11. HFpEF-related Atrial Fibrillation: From Mechanism to Clinical Implication of AF and Diastolic Dysfunction

July 26 (Fri) 10:00-11:30 Room 5 (302, 3F, Conference Center)

Chairs Stanley Nattel, University of Montreal, Canada

Eiichi Watanabe, Fujita Health University School of Medicine, Japan

SY11-1-KL. Effects of Diastolic Dysfunction on the Atria and Links to Arrythmia Mechanisms

Stanley Nattel, University of Montreal, Canada

SY11-2. The Behavior of Atrial Fibrillation in Patients with Heart Failure Hospitalization—Insight from Kokura Congestive Heart Failure Registry

Masato Fukunaga, Kokura Memorial Hospital, Kitakyushu, Japan

SY11-3. Sympathetic Tone and Atrial Fibrillation in Patients with HFpEF

Peng-Sheng Chen, Indiana University School of Medicine, USA

SY11-4. The Relationship between Outcome Undergoing Pulmonary Vein Isolation and Influence of Diastolic Function in Paroxysmal Atrial Fibrillation Patients with Preserved Ejection Fraction

Takashi Komatsu, Iwate Medical University, Japan

SY11-5. Clinical Benefit of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction

Keiji Inoue, Kyoto Second Red Cross Hospital, Japan


12. S-ICD: What’s New?

July 26 (Fri) 16:30-18:00 Room 6 (303, 3F, Conference Center)

Chairs Yuji Nakazato, Department of Cardiology, Juntendo University Urayasu Hospital, Japan

Antonio Raviele, ALFA-Alliance to Fight Atrial Fibrillation, Italy

SY12-1-KL. Combined Use of S-ICD and Pacemakers: Feasibilityand Results

Antonio Raviele, ALFA-Alliance to Fight Atrial Fibrillation, Italy

SY12-2. Indication

Masahiko Takagi, Division of Cardiac Arrhythmia, Kansai Medical University Medical Center, Japan

SY12-3. Clinical Results

Chu-Pak Lau, Queen Mary Hospital, The University of Hong Kong, Hong Kong

SY12-4. Implantation-Related Complications of the Subcutaneous Implantable Cardioverter-Defibrillator: A surgical management

Katsuhiko Imai, Department of Cardiovascular Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan


13. Long Term Efficacy and Safety in His-bundle Pacing

July 27 (Sat) 09:00-10:30 Room 1 (Main Hall, 1F, Conference Center)

Chairs Kyoko Soejima, Kyorin University School of Medicine, Japan

Pugazhendhi Vijayaraman, Geisinger Wyoming Valley Medical Center, USA

SY13-1-KL.

Pugazhendhi Vijayaraman, Geisinger Wyoming Valley Medical Center, USA

SY13-2. Implantation Technique and ECG Characteristic of Left Bundle Branch Pacing

Wejian Huang, Department of cardiology, the First affiliated hospital of Wenzhou Medical University, Japan

SY13-3. Characteristics of His-Bundle Electrogram at Implant Related to Pacing Threshold After Implant

Toshiaki Sato, Kyorin University, Medical School, Division of Advanced Arrhythmia Management, Japan

SY13-4. Predictors of Adequate Placement of His-Bundle Pacing Lead

Shinji Mito, Tsuchiya General Hospital, Japan

SY13-5. Efficacy and Safety of Monthly Remote Monitoring in His-Bundle Pacing Patients

Daisuke Yoshimoto, Toyohashi Heart Center, Toyohashi, Japan

SY13-6. A Comparison of Hemodynamic Parameters between His Bundle Pacing and Biventricular Pacing in CRT-indicated Patients with Left Bundle Branch Block

Hiroyuki Kato, Division of Cardiology, JCHO Chukyo Hospital, Japan


14. Unresolved Issues of Cardiac Device and Lead Extraction

July 27 (Sat) 10:30-12:00 Room 1 (Main Hall, 1F, Conference Center)

Chairs Morio Shoda, Department of Cardiology, Tokyo Women's Medical University, Japan

Bruce L. Wilkoff, Cleveland Clinic Lerner College of Medicine of CWRU, USA

SY14-1-KL.

Bruce L. Wilkoff, Cleveland Clinic Lerner College of Medicine of CWRU, USA

SY14-2. Various Methods of Lead Extraction in Patients with Large Vegetation

Nobuhiro Nishii, Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan

SY14-3. Clinical and Procedural Features of Left Ventricular Lead Extraction in Patients with Cardiac Resynchronization Therapy

Daigo Yagishita, Department of Cardiology, Tokyo Women's Medical University, Japan

SY14-4. Predictors of Bailout Femoral Approach in Transvenous Lead Extraction: A Propensity-Matched Analysis

Tsuyoshi Isawa, Sendai Kousei Hospital, Japan


15. Clinical Impact and Indication of Novel Devices and Surgical Procedures for Left Atrial Appendage Closure

July 27 (Sat) 13:50-15:20 Room 1 (Main Hall, 1F, Conference Center)

Chairs Takashi Nitta, Cardiovascular Surgery, Nippon Medical School, Japan

Haruhiko Abe, Department of Heart Rhythm Management, University of Occupational & Enviromental Health, Japan

SY15-1. Predictors of Incomplete Occlusion of the Left Atrial Appendage in Patients with a WATCHMAN Device Implantation

Koji Miyamoto, Division of Cardiovascular Diseases, Mayo Clinic, USA/ Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan

SY15-2. The Effect of Percutaneous Left Atrial Appendage Suture Ligation on Left Atrial Physiology

Hiroyuki Ito, Division of Cardiology, Department of Medicine, Showa University, Japan

SY15-3. Efficacy and Safety of Thoracoscopic Left Atrial Appendectomy in Patients with persistent Atrial Fibrillation

Yoko Ito, Tsukuba Memorial Hospital, Japan

SY15-4. Thoracoscopic Stand-Alone Left Atrial Appendage Closure with Stapler-And-Loop Technique in Non-Valvular Atrial Fibrillation: Mid-Term Results of 201 Cases

Toshiya Ohtsuka, Tokyo Metropolitan Tama Medical Center, Japan

SY15-5. 12-Months Outcome After Left Atrial Appendage Closure in Japanese Patients: Lesson from the SALUTE Trial

Hiro Yamasaki, University of Tsukuba, Japan


16. Emerging 3-D Mapping Systems for Diagnosis and Management of Arrhythmias

July 27 (Sat) 09:00-10:30 Room 5 (302, 3F, Conference Center)

Chairs Ichiro Sakuma, School of Engineering, The University of Tokyo, Japan

Hiroshi Nakagawa, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, USA

SY16-1-KL.

Hiroshi Nakagawa, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, USA

SY16-2. Comparison of Technological Features of High-density Mapping Systems

Yasuaki Tanaka, Yokosuka Kyosai Hospital, Japan

SY16-3. Mapping of Atrial Fibrillation Using a Novel Mapping Module: CARTOFINDER

Yoshihide Takahashi, Advanced Arrhythmia Research, Tokyo Medical and Dental University, Japan

SY16-4. Fluoro-Reduction Strategy with ACL and 3D Image-Integration

Satoru Sakagami, National Hospital Organization Kanazawa Medical Center, Japan

SY16-5. Catheter Ablation Performed in the Early Post-Operative Period after Congenital Heart Surgery

Jun Yoshimoto, Department of Cardiology, Shizuoka Children's Hospital, Shizuoka Japan

Meet the Asian Leaders

History, Scientific Contribution and Future Perspective of APHRS and the Expected Role of JHRS

July 25 (Thu) 11:15-12:30 Room 4 (301, 3F, Conference Center)

Chairs Wataru Shimizu, Department of Cardiovascular Medicine, Nippon Medical School, Japan

Tachapong Ngarmukos, Ramathibodi Hospital, Mahidol University, Thailand

Angelo Auricchio, Cardiocentro Ticino, Switzerland

Thomas F. Deering, Piedmont Hospital, USA

MAL-1. History of APHRS

Shih-Ann Chen, Taipei Veterans General Hospital, Taiwan

MAL-2. Scientific Contributions of APHRS

Young-Hoon Kim, Korea University Medical College, Anam Hospital, Korea

MAL-3. Intercontinental Relationship of APHRS with HRS and EHRA

Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia

MAL-4. Public Education Efforts and Fruitful Outcome in Asian Pacific Countries

Wee Siong Teo, National Heart Centre Singapore, Singapore

MAL-5. Future Perspective of APHRS

Chu-Pak Lau, Queen Mary Hospital, The University of Hong Kong, Hong Kong

MAL-6. The Expected Role of JHRS in APHRS

Kyoko Soejima, Kyorin University School of Medicine, Japan

MAL-7. Short Remark

Masayasu Hiraoka, Hiraoka-Clinic, Japan

Special Program

1. Complex Fractionated Atrial Elecatrogram Guided Ablation
—Further Learning More Refined Targets in AF Ablation

July 25 (Thu) 16:00-17:00 Room 7 (304, 3F, Conference Center)

Chairs Julien Seitz,Hôpital Saint Joseph, France

Kohei Yamashiro, Heart Rhythm Center, Aijinkai Takatsuki Hospital, Japan

SP1-1. Historical Perspective of Complex Fractionated Atrial Elecatrogram Guided Ablation

Naoya Oketani, Cardiovascular Medicine, Kagoshima City Hospital, Japan

SP1-2. Spatiotemporal Electrogram Dispersion Guided Ablation: What is different from Historical CFAE Ablation?

Julien Seitz, Hôpital Saint Joseph, France

SP1-3. Background of STD Guided Ablation from Translational Research

Masatoshi Yamazaki, Medical Device Development and Regulation Research Center, The University of Tokyo, Japan

3. Current Status and Future Perspective in the Pharmacological Antiarrhythmic Therapy

July 26 (Fri) 08:30-10:00 Room 4 (301, 3F, Conference Center)

Chairs Takeshi Yamashita,The Cardiovascular Institute, Japan

Tetsushi Furukawa, Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Japan

SP3-1. Channel Gating Modifiers as Novel and Effective, Antiarrhythmic Drug Therapy

Hraryer S. Karagueuzian, David Geffen School of Medicine at UCLA, USA

SP3-2. How to Use a New Channel Drug Ivabradine

Tomomi Ide, Kyushu University Hospital, Japan

SP3-3. Arrhythmia Treatment Targeting Rysnodinereceptor

Shigeki Kobayashi, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Japan

SP3-4. How Can We Use Existing Antiarrhthmicssafely

Takashi Komatsu, Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Japan

4. Message from US Specialists in the Management of CIED Infection

July 26 (Fri) 11:30-12:30 Room 7 (304, 3F, Conference Center)

Chairs & Speakers Charles J. Love, Johns Hopkins School of Medicine, USA

Bruce L. Wilkoff, Cardiac Pacing & Tachyarrhythmia Devices, Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, USA

HRS-JHRS Joint Symposium (HRS-JHRS)

Tough Cases! (Ablation and Devices)

July 27 (Sat) 10:30-12:00 Room 4 (301, 3F, Conference Center)

Chairs Akihiko Nogami, Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan

Thomas F. Deering, Piedmont Hospital, USA

HRS-JHRS-1-KL. Talk International Relationship between HRS and JHRS

Thomas F. Deering, Piedmont Hospital, USA

HRS-JHRS-2. Touch Ablation Cases

Samuel J. Asirvatham, Mayo Clinic, USA

HRS-JHRS-3. Touch Device Cases

Pugazhendhi Vijayaraman, Geisinger Wyoming Valley Medical Center, USA

HRS-JHRS-4. Catheter Ablation of Biatrial Tachycardia: A Journey to the Final Destination

Shigeki Kusa, Cardiovascular Division, Tsuchiura Kyodo Hospital, Japan

HRS-JHRS-5. Device (JHRS)

Katsuhito Fujiu, Department of Cardiovascular Medicine, The University of Tokyo, Japan

EHRA-JHRS Joint Symposium

The Current Perspective in Ablation Therapy

July 25 (Thu) 08:30-10:00 Room 4 (301, 3F, Conference Center)

Chairs Takashi Kurita, Division of Cardiovascular Center, Kindai University, Japan

Angelo Auricchio, Cardiocentro Ticino, Switzerland

EHRA-JHRS-1. LAA as Substrate of AF

Seiichiro Matsuo, Jikei University Katsushika Medical Center, Japan

EHRA-JHRS-2. Qdot -Novel RF Energy Delivery-

Josef Kautzner, Institute for Clinical Experimental Medicne (IKEM), Czech Republic

EHRA-JHRS-3. Hybrid Thoracoscopic Epicardial Ablation in Patients with Brugada Syndrome

Carlo De Asmundis, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Belgium

EHRA-JHRS-4. MRI as a Modality for Evaluating Pre-Ablation Structural Remodeling of Left Atrium-From Past to Future Perspective

Koji Higuchi, Hiratsuka Kyosai Hospital, Japan

APHRS-JHRS Joint Symposium

Malignant Ventricular Arrhythmias-Current Topics of Mapping and Catheter Ablation-

July 25 (Thu) 10:00-11:15 Room 4 (301, 3F, Conference Center)

Chairs Kyoko Soejima, Kyorin University School of Medicine, Japan

Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia

1. Catheter Ablation of Lamin Cardiomyopathy, LV Non Compaction, Hypertrophic Cardiomyopathy and Other Unusual Substrates

Saurabh Kumar, Westmead Hospital, Australia

2. Thermal Effect on the Development of Malignant Ventricular Arrhythmias in Brugada Syndrome

Fa-Po Chung, Taipei Veterans General Hospital, Taiwan

3. Epicardial VT in Non-Ischemic Cardiomyopathy: Unsolved Difficulty

Yukio Sekiguchi, Depatment of Cardiology, Faculty of Medicine, University of Tsukuba, Japan

4. Substrates and Trigger Ablation of Patients with Long QT Syndrome

Yoga Yuniadi, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, and National Cardiovascular Center Harapan Kita, Indonesia